View in EDS

1223P Homologous recombination deficiency (HRD) testing on ovarian cancer ascites: A feasibility study.

Saved in:
Bibliographic Details
Title: 1223P Homologous recombination deficiency (HRD) testing on ovarian cancer ascites: A feasibility study.
Authors: Ranghiero, A.1 (AUTHOR), Guerini Rocco, E.2 (AUTHOR), Rappa, A.1 (AUTHOR), Varcica, D.1 (AUTHOR), Taormina, S.V.1 (AUTHOR), Adorisio, R.1 (AUTHOR), Marinucci, L.1 (AUTHOR), Betella, I.3 (AUTHOR), Aletti, G.4 (AUTHOR), Colombo, N.5 (AUTHOR), Fusco, N.2 (AUTHOR), C. casadio6 (AUTHOR), Di Tonno, C.1 (AUTHOR), Barberis, M.1 (AUTHOR)
Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS717-S717. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2023.09.2312